Latest Period
Q2 2026
Security Snapshot
Evolus, Inc. - Common Stock (EOLS) Institutional Ownership
CUSIP: 30052C107
13F Institutional Holders and Ownership History from Q1 2016 to Q2 2026
Institutions Reporting
156
Shares (Excl. Options)
48,320,491
Price
$6.94
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- EOLS on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 48,320,491
- Total 13F value
- $335,138,349
- Portfolio coverage rank
- 0%
- Share change
- +2,754,272
- Value change
- +$21,708,236
- Number of holders
- 156
- Shares outstanding
- 64,879,792
- SEC-reported price per share
- $6.18
- Insider filing price
- $6.18
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- EOLS - Evolus, Inc. - Common Stock is tracked under CUSIP 30052C107.
- 156 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 143 to 156 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $186,970,617 to $335,138,349.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 156 institutions filings for Q2 2026.
Security key
30052C107
Latest holder period
Q2 2026
13F holders
156
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
EOLS full holder history
Evolus, Inc. SEC filings
Evolus, Inc. company facts
Evolus, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 30052C107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
EOLS
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| LYNCH TIMOTHY P | 9.9% | +25% | $36,305,352 | +$7,299,518 | 6,425,726 | +25% | Timothy P. Lynch | 31 Dec 2025 |
| Nantahala Capital Management, LLC | 8.8% | +49% | $35,162,902 | +$12,129,656 | 5,726,857 | +53% | Nantahala Capital Management, LLC | 30 Sep 2025 |
| BlackRock, Inc. | 6.9% | $50,851,038 | 4,364,896 | BlackRock, Inc. | 31 Dec 2024 | |||
| PERCEPTIVE ADVISORS LLC | 3.8% | -43% | $23,461,512 | -$15,682,755 | 2,474,843 | -40% | Perceptive Advisors LLC | 30 Jun 2025 |
| Medytox Inc. | 3.4% | $24,889,631 | 2,136,449 | Medytox Inc. | 31 Dec 2024 | |||
| TANG CAPITAL MANAGEMENT LLC | 1.9% | -75% | $7,038,160 | -$21,197,145 | 1,245,692 | -75% | TANG CAPITAL MANAGEMENT, LLC | 31 Dec 2025 |
As of 30 Jun 2026, 156 institutional investors reported holding 48,320,491 shares of Evolus, Inc. - Common Stock (EOLS). This represents 74% of the company’s total 64,879,792 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
63%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 8.6% | 5,602,021 | -12% | 2.3% | $38,878,026 |
| BlackRock, Inc. | 7.5% | 4,840,828 | +13% | 0% | $33,595,347 |
| BRAIDWELL LP | 4.9% | 3,155,209 | +1.6% | 0.81% | $21,897,150 |
| Frazier Life Sciences Management, L.P. | 4.1% | 2,630,665 | 0% | 0.4% | $18,256,815 |
| PERCEPTIVE ADVISORS LLC | 3.8% | 2,459,285 | +91% | 0.27% | $17,067,438 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 2,362,893 | -4.4% | 0% | $16,398,477 |
| MILLENNIUM MANAGEMENT LLC | 2.8% | 1,787,929 | +22% | 0.01% | $12,408,227 |
| STATE STREET CORP | 2.6% | 1,697,294 | +29% | 0% | $11,779,220 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.5% | 1,608,394 | +16% | 0% | $11,165,325 |
| Stonepine Capital Management, LLC | 2.5% | 1,590,162 | -9.6% | 8.4% | $11,035,724 |
| Point72 Asset Management, L.P. | 2.3% | 1,508,518 | 0.02% | $10,469,115 | |
| PINNACLE ASSOCIATES LTD | 2.3% | 1,487,264 | +28% | 0.11% | $10,321,612 |
| ARMISTICE CAPITAL, LLC | 2.2% | 1,436,000 | +2.9% | 0.28% | $9,965,840 |
| RICE HALL JAMES & ASSOCIATES, LLC | 2% | 1,289,888 | +2.8% | 0.44% | $8,951,823 |
| GOLDMAN SACHS GROUP INC | 1.9% | 1,219,419 | +12% | 0% | $8,462,768 |
| Assenagon Asset Management S.A. | 1.4% | 908,180 | +52% | 0.01% | $6,302,769 |
| Soleus Capital Management, L.P. | 1.3% | 822,428 | -63% | 0.2% | $5,707,650 |
| Soviero Asset Management, LP | 1.2% | 770,000 | +13% | 2.6% | $5,343,800 |
| UBS Group AG | 1.2% | 752,679 | -0.03% | 0% | $5,223,592 |
| AWH Capital, L.P. | 0.96% | 625,000 | 0% | 3% | $4,337,500 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.84% | 545,702 | +14% | 0% | $3,787,172 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.82% | 530,843 | +3% | 0% | $3,684,050 |
| CITADEL ADVISORS LLC | 0.78% | 506,354 | -27% | 0% | $3,514,097 |
| NORTHERN TRUST CORP | 0.77% | 497,018 | +5.2% | 0% | $3,449,306 |
| VANGUARD FIDUCIARY TRUST CO | 0.7% | 456,183 | +7.4% | 0% | $3,165,910 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
36
Latest
Q2 2026
Rows shown
1-25 of 36
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 48,320,491 | $335,138,349 | +$21,708,236 | $6.94 | 156 |
| 2026 Q1 | 45,487,311 | $186,970,617 | -$24,787,153 | $4.11 | 143 |
| 2025 Q4 | 49,221,799 | $327,344,392 | -$41,089,898 | $6.65 | 169 |
| 2025 Q3 | 54,269,920 | $333,221,285 | -$49,039,353 | $6.14 | 158 |
| 2025 Q2 | 58,306,002 | $536,933,982 | +$27,282,114 | $9.21 | 171 |
| 2025 Q1 | 54,269,937 | $652,886,328 | +$25,547,799 | $12.03 | 178 |
| 2024 Q4 | 51,921,808 | $573,114,520 | +$6,665,899 | $11.04 | 164 |
| 2024 Q3 | 50,293,278 | $814,501,081 | -$14,779,328 | $16.20 | 164 |
| 2024 Q2 | 51,340,763 | $557,051,494 | +$21,839,886 | $10.85 | 155 |
| 2024 Q1 | 49,347,816 | $690,868,493 | +$53,544,087 | $14.00 | 160 |
| 2023 Q4 | 45,541,929 | $479,552,344 | +$47,465,780 | $10.53 | 149 |
| 2023 Q3 | 41,447,331 | $378,821,815 | +$40,085,326 | $9.14 | 135 |
| 2023 Q2 | 37,278,540 | $271,085,912 | +$16,634,153 | $7.27 | 132 |
| 2023 Q1 | 34,126,762 | $288,714,148 | +$41,941,872 | $8.46 | 124 |
| 2022 Q4 | 29,273,655 | $219,845,469 | +$14,363,180 | $7.51 | 116 |
| 2022 Q3 | 25,565,680 | $205,795,765 | -$5,087,386 | $8.05 | 122 |
| 2022 Q2 | 25,348,901 | $294,043,424 | +$27,306,633 | $11.60 | 117 |
| 2022 Q1 | 23,065,245 | $258,202,339 | +$27,115,832 | $11.22 | 115 |
| 2021 Q4 | 20,576,998 | $133,137,102 | +$16,160,367 | $6.51 | 102 |
| 2021 Q3 | 17,623,312 | $134,773,188 | +$2,126,205 | $7.62 | 109 |
| 2021 Q2 | 16,226,875 | $205,283,641 | +$96,350,898 | $12.65 | 111 |
| 2021 Q1 | 8,608,655 | $111,825,892 | +$19,807,970 | $12.99 | 92 |
| 2020 Q4 | 7,776,423 | $26,127,429 | +$1,508,358 | $3.36 | 79 |
| 2020 Q3 | 7,265,841 | $28,771,905 | -$11,631,486 | $3.91 | 77 |
| 2020 Q2 | 9,284,051 | $49,207,493 | -$20,294,810 | $5.30 | 80 |